Inflamax Research is a full-service, global Contract Research Organization specializing in allergy, dermatology, ophthalmic and respiratory diseases, led by world-known, key-opinion leaders. Inflamax is renowned for its strong leadership, innovation, deep scientific expertise and clinical experience. Inflamax has a strong academic background and publishes extensively in peer-reviewed journals. Inflamax is experienced in the conduct of Phase I-IV large single and multi-centre trials using their innovative fixed and mobile Environmental Exposure Chambers and direct instillation models from a study’s concept to protocol writing, site management, data management, and medical writing. Inflamax’s scientists and clinicians are well known to regulatory authorities and regularly participate in an advisory role.